Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Blood-Brain Barrier Permeability
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of the study is to confirm the applicability and usefulness of the novel method of assessment of the permeability of the blood-brain barrier and in monitoring of the treatment of patients with meningitis. The proposed technique is based on evaluation of the kinetics of the indocyanine green (ICG) outflow from the brain with the use of near-infrared spectroscopy (NIRS). Usefulness of the NIRS-based method will be analyzed in relation to the reference method, which is contrast-enhanced magnetic resonance imaging (MRI).

Provided treatments

  • Other: ICG-PULSION
  • Device: LiMON, Pulsion Medical Systems
  • Other: Gadolinium (Gadovist, Bayer, Germany)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02902588. The sponsor of the trial is Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences and it is looking for 40 volunteers for the current phase.
Official trial title:
The Use of Near Infrared Spectroscopy and Magnetic Resonance Imaging Technique in the Evaluation of the Permeability of Blood-brain Barrier in Adults With Meningitis